Showing results (201-210 of 302) with videos related to

Sort By:
Pageof 31
British Journal of Haematology|August 12, 2015
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphomaDai Chihara, Barbara Pro, Sanam Loghavi, et al.
Blood Advances|September 3, 2021
Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphomaSattva S Neelapu, Frederick L Locke, Nancy L Bartlett, et al.
Cancer|June 29, 2016
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphomaDai Chihara, Jason R Westin, Yasuhiro Oki, et al.
Blood|February 29, 2012
Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphomaAnas Younes, Yasuhiro Oki, Peter McLaughlin, et al.
Leukemia|April 28, 2019
CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activityFuliang Chu, Haiyan S Li, Xindong Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2025
Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical StudiesFrederick L Locke, Javier L Munoz, Michael T Tees, et al.
British Journal of Haematology|July 21, 2022
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphomaPaolo Strati, Morton Coleman, Rebecca Champion, et al.
Oncotarget|November 19, 2016
A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemiaNeil E Kay, Paolo Strati, Betsy R LaPlant, et al.
Blood Cancer Discovery|May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell LymphomaNeeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
Blood|June 27, 2013
Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemiaPaolo Strati, Michael J Keating, William G Wierda, et al.
Pageof 31